Shu Hui Chen
Corporate Officer/Principal presso WUXI PHARMATECH (CAYMAN) INC. (ADR)
Profilo
Attualmente, Shu Hui Chen è vicepresidente di WuXi AppTec Co., Ltd. e direttore scientifico di Wuxi PharmaTech (Cayman) Inc. In passato è stato consulente di ricerca presso Eli Lilly & Co., direttore associato di chimica presso Vion Pharmaceuticals, Inc. e ricercatore senior presso Bristol-Myers Squibb Co. Il dottor Chen ha ricevuto un dottorato dalla Yale University e una laurea presso la Fudan University.
Posizioni attive di Shu Hui Chen
Società | Posizione | Inizio |
---|---|---|
WUXI PHARMATECH (CAYMAN) INC. (ADR) | Corporate Officer/Principal | - |
Precedenti posizioni note di Shu Hui Chen
Società | Posizione | Fine |
---|---|---|
WUXI APPTEC CO., LTD. | Chief Tech/Sci/R&D Officer | 23/03/2016 |
ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2004 |
Vion Pharmaceuticals, Inc.
Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Corporate Officer/Principal | 01/01/1997 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/1995 |
Formazione di Shu Hui Chen
Yale University | Doctorate Degree |
Fudan University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
WUXI APPTEC CO., LTD. | Health Technology |
Aziende private | 2 |
---|---|
Vion Pharmaceuticals, Inc.
Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Health Technology |
Wuxi PharmaTech (Cayman), Inc.
Wuxi PharmaTech (Cayman), Inc. Pharmaceuticals: MajorHealth Technology Wuxi PharmaTech (Cayman), Inc. engages in the provision of research and development outsourcing services for the pharmaceutical, biotechnology and medical device industries. It operates through the laboratory services and manufacturing services segments. The laboratory services segment offers pharmaceutical and biotech services including discovery and medicinal chemistry, discovery biology, safety pharmacology, bioanalytical services, process research, formulation and toxicology laboratory services, as well as testing services for biologics, medical devices and combination products. The manufacturing services segment involves the production of intermediates and active pharmaceutical ingredients for or preclinical and clinical trials of small-molecule and commercial products; and biologics. The company was founded by Ge Li, Xiao Zhong Liu, Zhao Hui Zhang and Ning Zhao in 2000 and is headquartered in Shanghai, China. | Health Technology |
- Borsa valori
- Insiders
- Shu Hui Chen